Breast Tissue Markers Market Foreseen to Grow Exponentially till 2031

Breast Tissue Markers Market Outlook 2031

The global breast tissue markers market was valued at US$ 2.5 Bn in 2021
The global market is projected to advance at a CAGR of 8.3% from 2022 to 2031
The global breast tissue markers market is anticipated to reach more than US$ 5.8 Bn by the end of 2031

Read Report Overview: https://www.transparencymarketresearch.com/breast-tissue-markers-market.html

Breast Tissue Markers Market Introduction

Breast tissue markers are commonly used in mammography diagnostic imaging. Typically, these are implanted just after a percutaneous biopsy under ultrasonic or stereotactic guidelines. On follow-up imaging, these can be extremely helpful in identifying relatively harmless regions or shrinking/treated malignant lesions. Breast tissue markers are now available in various shapes, compositions, and partially bio-absorbable components. Ribbon, coil, and wing markers with easily distinguishable appearances on mammograms are among the makers currently in use. New ultrasound-detectable markers are also available in the market. Breast tissue markers can be used to guide subsequent radiotherapy treatments with clips inserted prior to surgery (localization wire targets).

Request a Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=79500

Increase in Demand for Biodegradable Breast Tissue Markers Driving Global Market

In a biopsy procedure, a metal clip with a 3 mm diameter is commonly used as a radio marker so that the lesion can be clearly identified on subsequent imaging inspection. A metal clip marker remains in the breast indefinitely. This is a significant disadvantage. Therefore, most women refuse to have a biopsy. This is exacerbated when a patient has had numerous breast biopsies and much more than a metal clip marker is implanted to differentiate abnormal lesions on a mammography. Furthermore, metal clips migrate away from the biopsy insertion site after deployment. Another disadvantage of metal markers is that they cause issues during MRI because of changes in the local magnetic field caused by the implants' ferromagnetic, paramagnetic, and diamagnetic properties. This could reduce MRI's sensitivity for breast cancer detection and treatment monitoring. Therefore, biodegradable breast tissue markers are being developed as implants in the breast biopsy market. These biodegradable breast biopsy markers have the potential to serve as visual markers for breast tumor growth regions for the required follow-up period, such as six months, before being completely eliminated from the body.

Request Report Methodology: https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=79500

Breast Cancer Awareness and Screening Programs Fueling Global Market

Regional government authorities are launching breast cancer awareness and screening programs to reduce the mortality rates associated with breast cancer. Breast cancer therapeutics are becoming more effective in the treatment of the disease, with more than 90% survival probabilities, especially when the disease is detected early. According to the World Health Organization, around 2.3 million new cases of breast cancer and 685,000 deaths were recorded globally in 2020. Breast cancer has been diagnosed in 7.8 million women in the previous five years ending 2020, making it the world's most common cancer.

Initiation of breast cancer awareness campaigns by public organizations is expected to encourage breast cancer learning and breast cancer therapeutic applications. The National Breast Cancer Foundation launched 'October as Breast Cancer Awareness Month,' a campaign to increase awareness about the dangers of breast cancer. Such efforts are expected to encourage recently diagnosed breast cancer patients, thereby driving the global market.

Ask References: https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=79500

Rise in Number of Breast Biopsy Procedures Offering Growth Opportunities to Market Players

Breast biopsies are typically used to diagnose breast cancer, but these can also be used to screen for other diseases discovered during a physical examination. Breast biopsies are commonly performed using fine needle aspiration biopsy, which is one of the least invasive procedures available. It also does not leave any scarring. A needle is inserted through the dermal tissue of the breast to remove tissue. Another technique, known as stereotactic needle biopsy in combination with a mammogram, guides this same biopsy with ultrasound radiation. The ultrasound tracker directs the needle to the chosen place in the breast during treatment. Stereotactic mammography is a method that employs images taken from different vantage points to identify the site of a malignant tumor in addition to the placement of the needle used to acquire a breast biopsy sample. Thus, breast marker is a small titanium or stainless steel marker the size of a sesame seed. Breast biopsy markers are used to pinpoint the location of the breast tissue removed during a biopsy procedure.

Request For Custom Research: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=79500

Application in Identifying and Marking Biopsy Area Bolstering Coil Segment

In terms of product, the global breast tissue markers market has been classified into coil, ribbon, bowtie, butterfly, bowtie, U shape, and others. Coil breast tissue markers are commonly used in partially biodegradable breast tissue markers. These breast tissue markers help a surgeon diagnose and operate more effectively by identifying and marking the biopsy area with a physical tag. Furthermore, mergers and acquisitions are projected to drive the coil segment in the near future. For instance, Mammotome announced the launch of a new product line of flexible HydroMARK Breast Biopsy Site Marker applicators designed to improve the clinician's user experience. The new applicator line expands compatibility with leading vacuum-assisted breast biopsy systems, bringing the HydroMARK markers to more customers in more clinical settings.

Increase in Usage of Non-biodegradable Markers Across Globe

Based on material, the global breast tissue markers market has been bifurcated into partially biodegradable and non-biodegradable. Non-biodegradable clips are made up of titanium, with no absorbable PVA polymer pellet or other materials. Titanium is widely used in breast tissue markers. The breast tissue markers market is focusing on end-user education and training. Several companies operating in the global market are providing their products at reasonable prices.

Availability of High-quality Care Bolstering Hospitals Segment

In terms of end-user, the global breast tissue markers market has been divided into hospitals, ambulatory surgical centers, diagnostic centers, and specialty clinics. Increasing number of patients are seeking hospitals that provide patient-centered care. In other words, these hospitals establish a reputation of offering patients high-quality care, giving them a competitive edge over institutions that continue to rely on outdated practices. Overall decrease in hospital care expenses is also projected to drive the hospitals segment during the forecast period.

Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=79500

Analysis of Key Players in Global Breast Tissue Markers Market

The global breast tissue markers market is consolidated, with the presence of a small number of leading players. Most of the companies are investing significantly in R&D activities, primarily to introduce advanced breast tissue markers such as BioZorb tissue markers. Key players are engaging in strategic alliances to increase revenue and market share. Furthermore, diversification of product portfolios and mergers & acquisitions are the major strategies adopted by the players. Mammotome, BD, Hologic, Inc., Carbon Medical Technologies, Inc., Scion Medical Technologies, LLC, Mermaid Medical, and SOMATEX Medical Technologies GmbH are prominent players operating in the global breast tissue markers market.

Key Developments in Global Breast Tissue Markers Market

In December 2021, Roche released its most recent digital pathology algorithms based on artificial intelligence (AI) to help pathologists evaluate Ki-67, ER, and PR breast cancer markers. The decision to choose a patient's therapy could be affected by the laborious manual methods for quantification of breast cancer markers, which have reported significant interobserver variability.
In 2021, Hologic, Inc., an innovative medical technology company primarily focused on improving women's health, announced the completion of the acquisition of SOMATEX Medical Technologies GmbH for around US$ 64 Mn. E-Med Solutions GmbH, a group of investors led by Westlake Partners, a Germany-based private equity firm, previously owned the company.
Each of these players has been profiled in the breast tissue markers market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

This release was published on openPR.